Bioorganic and Medicinal Chemistry Letters p. 3637 - 3642 (1998)
Update date:2022-08-02
Topics:
Salituro, Francesco G.
Baker, Christopher T.
Court, John J.
Deininger, David D.
Kim, Eunice E.
Li, Biquin
Novak, Perry M.
Rao, Bhisetti G.
Pazhanisamy
Porter, Margaret D.
Schairer, Wayne C.
Tung, Roger D.
A set of HIV protease inhibitors represented by compound 2 has previously been described. Structural and conformational analysis of this compound suggested that conformational restriction of the P1/P2 portion of the molecule could lead to a novel set of potent protease inhibitors. Thus, probe compounds 3-7 were designed, synthesized, and found to be potent inhibitors of HIV protease.
View Morewebsite:http://www.shochem.com
Contact:021-50800795
Address:No.1043, Halei Rd, Zhangjiang Hi-Tech Park, Shanghai, Postcode 201203, China
Lyrin Industrial Corporation Limited
Contact:86-731-82571800
Address:Rm 2408,Asia Economy International Building,Shaoshan Road South,Yuhua District,Changsha,Hunan,China
Jiangsu Zenji Pharmaceuticals LTD
Contact:+86-025-83172562; +1-224-888-1133(USA)
Address:No.5 Xinmofan Road
Anhui Eapearl Chemical Co., Ltd.
Contact:86-562-5858458
Address:358 South Huaihe Road
Contact:13813902930 025-52714267
Address:20 Fengji Road, Yuhua Economic Development Zone, Nanjing, Jiangsu, P. R. China
Doi:10.1002/hlca.19660490533
(1966)Doi:10.1016/S0022-328X(97)00345-8
(1997)Doi:10.1016/S0040-4039(97)10854-1
(1998)Doi:10.4039/Ent133333-3
(1954)Doi:10.1016/S0040-4039(00)02252-8
(2001)Doi:10.1016/S0040-4020(97)00940-X
(1997)
